Arteric Guides Healthcare Marketing Leaders on Practical Applications of Artificial Intelligence (AI) to Uncover Unmet Customer Needs

Arteric Guides Healthcare Marketing Leaders on Practical Applications of Artificial Intelligence (AI) to Uncover Unmet Customer Needs

Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - March 04, 2019 - Arteric

Standigm Launches Artificial Intelligence-Driven Drug Discovery Service at 2019 BIO-Asia International Conference in Tokyo, Japan

Standigm, a company using the advanced AI technology to drug discovery, launched the customized early drug discovery and target study service, "Standigm Insight®," at 2019 BIO-Asia International Conference in Tokyo, Japan. Standigm Insight® provides AI-driven new indication prediction and novel target analysis service for customer’s in-house products. - March 04, 2019 - Standigm

Apostle Inc. Enters Partnership with Beckman Coulter Life Sciences

Apostle Inc is pleased to announce an exclusive partnership with Beckman Coulter, a world leader in Life Sciences, for Apostle MiniMaxTMHigh Efficiency Cell-Free DNA Isolation Kit. As cell-free DNA (cfDNA) workflows move beyond theoretical and into human health applications, Apostle's industry... - February 28, 2019 - Apostle Inc

3D Preclinical Ultrasound Imaging System Launched in North America and Europe by Scintica Instrumentation

A 3D ultrasound imaging system for mice, rats and other small animals is now available to scientists throughout North America and Europe. The Prospect T1 is a cost effective, tablet based, high-frequency ultrasound imaging system, optimized to study hemodynamics and vascular function at the laboratory benchtop instead of from inside a core imaging facility. Scintica Instrumentation has the exclusive rights to sell and service the Prospect T1 with its team of scientific experts. - February 14, 2019 - Scintica Instrumentation Inc.

Sanyal Biotechnology Hires IQVIA / BuzzeoPDMA DEA Compliance Group

Sanyal Biotechnology Hires IQVIA / BuzzeoPDMA DEA Compliance Group

Sanyal Bio has expanded into pre-clinical and clinical contract research on cannabinoids. Sanyal Bio currently holds a DEA Schedule 1 Import License for Cannabis Extracts and THC, with applications pending for Research, Analytical and Manufacturing licenses. IQVIA's DEA Compliance group is well-respected for their expertise and Sanyal Bio looks forward to working with this reputable group going forward. - February 13, 2019 - Sanyal Biotechnology

immunoSCAPE Launches US Office

immunoSCAPE Pte Ltd ("immunoSCAPE" or the "Company"), a leader in immune profiling, today announced the establishment of its first US office in Cambridge, MA. The office will serve as the headquarters of its US based, wholly owned subsidiary immunoSCAPE, Inc. Mr. Choon Peng NG,... - February 11, 2019 - immunoSCAPE Pte Ltd

Plant Extract Can Help Prevent Cancer Recurrence says the Beljanski Foundation

Rauwolfia Vomitoria, a Natural Plant Extract, Inhibits Cancer Stem Cells - February 08, 2019 - The Beljanski Foundation

Milestone in Cancer Stem Cell Research by Beljanski Foundation

Research Shows Pao Pereira, a Natural Plant Extract, Inhibits Cancer Stem Cells. - February 08, 2019 - The Beljanski Foundation

ALPCO Announces January 2019 Young Investigator Award Recipient of Its Diabetes Research Travel Grant

ALPCO Announces January 2019 Young Investigator Award Recipient of Its Diabetes Research Travel Grant

ALPCO awards its January 2019 Diabetes Research Travel Grant to Lisa Volpatti at Massachusetts Institute of Technology. - February 05, 2019 - ALPCO

Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology

Paras Biopharmaceuticals Finland Oy Announces Successful Development of Biologically Active Romiplostim (N-Plate® Biosimilar) Production Technology

Paras Biopharmaceuticals Finland Oy today announced the achievement of a major milestone – the successful development of biologically active Romiplostim (N-Plate® biosimilar) production technology. Romiplostim has been produced with a proprietary and innovative continuous manufacturing... - January 31, 2019 - Paras Biopharmaceuticals Finland Oy

Hans Kaspersetz Joins Digital Pharma West Advisory Board

Hans Kaspersetz Joins Digital Pharma West Advisory Board

Digital Marketing Thought Leader to Help Craft Agenda for Leading Healthcare Marketing Conference. - January 25, 2019 - Arteric

Euphrates Vascular Announces FDA Clearance of the ICHOR Reperfusion System

Euphrates Vascular, a company focused on the treatment of vascular occlusions, recently received 510(k) clearance for sale of its ICHOR Percutaneous Reperfusion System. ICHOR is designed to treat organized thrombus and embolic events in the peripheral vasculature. This "one size fits all" system is minimally invasive. - January 24, 2019 - Euphrates Vascular

Global OrthoBiologic Expands Its Operation Under the Name Global REGENERATIVE Group (GRG)

Global OrthoBiologic Expands Its Operation Under the Name Global REGENERATIVE Group (GRG)

Global OrthoBiologic has announced today that it will expand its operation under the name Global REGENERATIVE Group (GRG) with headquarters to remain in Miami, Florida (globalregenerative.group) and will consist of 4 divisions, which will operate independently – Trade, Academy, Care and Finance. - January 16, 2019 - Global Regenerative Group

Pulse Therapeutics and ICHOR Vascular Merge to Form Euphrates Vascular

Company aimed at becoming a leader in the treatment of vascular occlusions. - January 13, 2019 - Euphrates Vascular

Bioquark Inc. and Ectocrine Technologies LLC to Collaborate on Mosquito-Derived Health Product Development

The common mosquito, while being responsible for up to a million human deaths each year, may paradoxically also hold biochemical secrets to cure diseases that effect hundreds of millions of people around the globe. - January 12, 2019 - Bioquark Inc.

Scintica Instrumentation to Distribute the Compact and Affordable MRI Preclinical System from Aspect Imaging

Scintica Instrumentation Inc. is excited to announce their distribution agreement in North America and Europe for Aspect Imaging’s preclinical M-Series™ Compact MRI system. The M-Series™ enable high-resolution 3D imaging without the need for special shielding, cryogens or water connections. Gold standard and affordable MR imaging can now be integrated into individual scientific laboratories, allowing researchers to harness the power and insights of MRI quickly and easily. - January 09, 2019 - Scintica Instrumentation Inc.

New Training Workshops Available in Orlando and Nationwide

D.L. Newslow & Associates, Inc. is now offering new quality-focused workshops in addition to a large stable of existing food safety training options. They are also the hosts of the TWI Institute Southeast and Mr. Alan Lane, the author of the Training Within Industry Management System Standard. - January 07, 2019 - D.L. Newslow & Associates, Inc.

Kannaki Ramamoorthy Joins Arteric as Quality Assurance Manager

Software-Development Veteran Leads Team Renowned for Impeccable Standards. - December 21, 2018 - Arteric

Clinical Safety and Efficacy Data of DSP-Visulex Published in Current Eye Research

Clinical Safety and Efficacy Data of DSP-Visulex Published in Current Eye Research

Aciont Inc. announced today that data from the clinical study of the DSP-Visulex technology is published online ahead of print in Current Eye Research. Reference: Papangkorn K, Truett KR, Vitale AT, Jhaveri C, Scales DK, Foster CS, Montieth A, Higuchi JW, Brar B, Higuchi WI. Novel dexamethasone sodium phosphate treatment (DSP-Visulex) for noninfectious anterior uveitis: a randomized phase I/II clinical trial. Current Eye Research. - December 06, 2018 - Aciont Inc.

GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2

GeneFluidics Selected as One of Five Finalists for Antimicrobial Resistance Diagnostic (AMR) Challenge Step 2

GeneFluidics is the only group selected for both NIAID antimicrobial resistance diagnostics projects (https://www.nih.gov/news-events/news-releases/nih-funds-nine-antimicrobial-resistance-diagnostics-projects) and as finalists for the NIH AMR Challenge Step 2 (https://dpcpsi.nih.gov/AMRChallenge/Finalists). - December 05, 2018 - GeneFluidics Inc.

Silas Kim Joins Arteric as Talent Acquisition Manager

Fills talent pool at rapidly growing healthcare digital marketing agency - November 30, 2018 - Arteric

Regenlab’s Patent Infringement Case Against Eclipse to Proceed in New York

Regenlab’s Patent Infringement Case Against Eclipse to Proceed in New York

District Court rules in favor of RegenLab to find venue over Eclipse in New York. RegenLab will continue its efforts to resolve allegations of infringement of its patent rights by manufacturers and distributors of the Eclipse PRP product. - November 29, 2018 - RegenLab

CrystalGenomics Signs Export Agreement with PharmArtis for Acelex in Russia

CrystalGenomics, Inc. announced today that they have signed an Export Agreement with PharmArtis International for the commercialization of Acelex® (polmacoxib) in Russia. Based on the terms of the agreement, CrystalGenomics will supply finished product of Acelex to PharmArtis and PharmArtis... - November 24, 2018 - CrystalGenomics, Inc.

Don Rodriguez Joins Arteric as Director, Analytics & Paid Search

Data Maven Brings a History of Double-Digit Growth in Client Revenue to a Growing Strategy, Analytics and Media Team. - November 16, 2018 - Arteric

Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing

Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing

Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result - November 07, 2018 - Arteric

Standigm Launches Artificial Intelligence-Driven Lead Optimization Service at BIO-Europe 2018 in Copenhagen, Denmark

Standigm, a company using the advanced AI technology to drug discovery, launched the customized lead optimization service, "Standigm BEST®," at BIO-Europe 2018 in Copenhagen, Denmark. Standigm BEST® provides AI-driven lead optimization and can also be utilized for fast-follow hit identification or patent fencing strategy. One-to-one meetings have been scheduled with leading pharmaceutical companies, indicating their interest in Standigm BEST®. - November 05, 2018 - Standigm

VIRUN® and Algarithm™ to Debut O3Omega™ NOT Peanut Butter and Jelly Sandwich Multi-serving Smoothies in Booth 1637 at Supply Side West Expo, Las Vegas on November 8 and 9

VIRUN® and Algarithm™ to Debut O3Omega™ NOT Peanut Butter and Jelly Sandwich Multi-serving Smoothies in Booth 1637 at Supply Side West Expo, Las Vegas on November 8 and 9

Virun® and Algarithm™ offer chill vibe at otherwise chaotic Supplyside West, serve up adult beverages enhanced with DHA and flavored like deserts, to debut new vegan O3Smoothies flavor, NOT Peanut Butter and Jelly. - November 02, 2018 - VIRUN

New Luxury Skincare from New Zealand Combines Bio-Technology and Sustainable Natural Ingredients to Fight Pollution and Premature Ageing

The Scotch & Tailor Skin Therapy system combines 15 years of medical research, biotechnology processes, and sustainable natural ingredients like Manuka Honey and natural keratin to bring you skin care built for modern living; protecting, nourishing and repairing skin from pollution, free... - November 01, 2018 - Scotch & Tailor

AdvantaPure(R) Introduces AdvantaSil(TM) Ultra Low Temperature Silicone Tubing That’s Engineered for Temperatures as Low as -112°C

New AdvantaSil Ultra Low Temperature Silicone Tubing is designed to aid pharmaceutical and biopharm manufacturers with protecting their high-value cell and drug products. The platinum-cured tubing is engineered for Single-Use applications involving cold storage and transport. It’s the first commercially-available tubing engineered for flexibility and crush resistance upon removal from a minus 86 degrees C freezer. A video on AdvantaPure’s website shows the test procedures and results. - November 01, 2018 - AdvantaPure

Creative Enzymes Has Launched New Product Called Pectolyase

Creative Enzymes has announced today that they had just launched a new product called Pectolyase, and declared that they had spent much time on the research and development for the completion of this product because it can greatly accelerate fruit juice filtration and promote clarification in fruit... - October 31, 2018 - Creative Enzymes

2018 (10th) International Conference on Stem Cells Will Commence in Beijing, China

2018 (10th) international conference on stem cells will be held in Beijing on November 9, 2018 and concluded on November 10, 2018. Based on the experience of the previous nine sessions of stem cell clinic and transformation, this conference will focus on stem cell reprogramming and regenerative... - October 28, 2018 - Creative Enzymes

Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Life Science Leader Summit

Arteric to Present on Practical Applications of Artificial Intelligence (AI) in Healthcare Marketing at Life Science Leader Summit

Two Case Studies Illustrate the Impact of AI on Accelerating Business, and the Insights That Result. - October 26, 2018 - Arteric

Monica D’Amico Joins Arteric as an Account Supervisor

Broad Digital Experience and Deep Client Commitment Augment Stellar Account Team. - October 26, 2018 - Arteric

cliexa Acquires Preventative Technology Solutions Inc.

cliexa Acquires Preventative Technology Solutions Inc.

cliexa® has acquired Colorado-based Preventative Technology Solutions Inc. and will incorporate their digital health solutions for adolescent resiliency into cliexa's existing platform for chronic care management. - October 25, 2018 - cliexa

ALPCO Launches FDA Class I Exempt STELLUX® Glucagon ELISA

ALPCO Launches FDA Class I Exempt STELLUX® Glucagon ELISA

ALPCO announces launch of its new highly specific FDA Class I Exempt STELLUX® Chemi Glucagon ELISA. - October 23, 2018 - ALPCO

Credo Biomedical to Present at Animal Health Innovation Summit

Credo Biomedical is one of the 12 finalists that have been selected to showcase during the Animal Health Innovation Summit in Hong Kong. - October 21, 2018 - Credo Biomedical Pte. Ltd.

Epitope Diagnostics, Inc. Certifies Its Total 25-OH Vitamin D EIA Kit Through the CDC’s Vitamin D Standardization-Certification Program (VDSCP)

Epitope Diagnostics, Inc. (EDI), is pleased to announce it has received certification for the Vitamin D Standardization Program (VDSP) for vitamin D measurement in the EDI™ Total 25-OH Vitamin D EIA Kit. CDC’s Vitamin D Standardization-Certification Program (VDSCP) evaluates the... - October 21, 2018 - Epitope Diagnostics, Inc.

Vascular BioSciences Awarded $2 Million Phase II STTR Grant From NHLBI to Develop CAR Peptide as a Targeted Therapy for Pulmonary Hypertension

Grant awarded in partnership with Brigham and Women’s Hospital, Harvard Medical School. - October 20, 2018 - Vascular BioSciences, Inc

OmicsLogic Bioinformatics Training Program Offered Through Louisiana Biomedical Research Network (LBRN)

OmicsLogic Bioinformatics Training Program Offered Through Louisiana Biomedical Research Network (LBRN)

LBRN (Louisiana Biomedical Research Network) together with Pine Biotech and the Tauber Bioinformatics Research Center from the University of Haifa, Israel have established a bioinformatics training program “OmicsLogic,” a comprehensive collection of modular resources in data science and molecular biology. The program emphasizes hands-on learning with relevant clinical and research examples. - October 18, 2018 - Pine Biotech

ALPCO Announces Inaugural Young Investigators Award Recipient

ALPCO Announces Inaugural Young Investigators Award Recipient

ALPCO announces the first recipient of its new young investigators award, the Diabetes Research Travel Grant. - October 17, 2018 - ALPCO

Tornado Spectral Systems Wins 2018 CPhI Pharma Award

Tornado Spectral Systems was recognized as the winner of the "Analysis, Testing, and Quality Control" award at the prestigious CPhI Pharma Awards (2018) in Madrid, Spain. The CPhI Pharma Awards are among the most coveted recognitions in the pharma industry, celebrating innovations breaking new ground and supporting companies committed to industry excellence. - October 17, 2018 - Tornado Spectral Systems

Arteric.com Captures Five More Website Design Awards

Arteric.com Captures Five More Website Design Awards

Total Number of Awards Reaches 13. - October 12, 2018 - Arteric

ALPCO’s Quality Management System Receives ISO 13485:2016 Certification

ALPCO’s Quality Management System Receives ISO 13485:2016 Certification

ALPCO announces that its quality management system recently received the distinguished ISO 13485:2016 certification from Intertek to ensure the quality, safety and efficacy of its products in the clinical diagnostics field. - October 09, 2018 - ALPCO

Arteric Sponsors Digital Pharma East

Digital Marketing Agency Continues Support of Major Healthcare Conference - October 05, 2018 - Arteric

Epitope Diagnostics, Inc. Joins MetroConnect to Expand International Growth

Epitope Diagnostics, Inc. is pleased to announce it has been selected to take part in MetroConnect 2018, an export assistance program run by the World Trade Center San Diego (WTC) and designed to help San Diego companies accelerate their global growth. This program will allow Epitope Diagnostics... - September 23, 2018 - Epitope Diagnostics, Inc.

Hans Kaspersetz to Moderate Panel at Healthcare Marketing Summit

Hans Kaspersetz to Moderate Panel at Healthcare Marketing Summit

Veteran Digital Marketing Strategist Guides Discussion on Personalization Strategies - September 21, 2018 - Arteric

cliexa-RA Implementation in Colorado Arthritis Center: A Case Study of Quadruple Aim Impacts

cliexa-RA Implementation in Colorado Arthritis Center: A Case Study of Quadruple Aim Impacts

cliexa® partners with the Colorado Arthritis Center to identify how screening and monitoring of Rheumatoid Arthritis patients through a customized electronic platform, cliexa-RA, impacts clinical efficiency. - September 21, 2018 - cliexa

Spherium’s Cyclatop (SP14019), Safe and Efficacious for the Treatment of Atopic Dermatitis in Adults and Infants

Spherium’s Cyclatop (SP14019), Safe and Efficacious for the Treatment of Atopic Dermatitis in Adults and Infants

The results of the clinical trial Cyclatop (NCT02865356) to investigate the safety, tolerability, pharmacokinetics and efficacy of SP14019 (Cyclosporine A 5% topical spray) across all group ages, for the treatment of mild to moderate atopic dermatitis, were presented today at the EADV Congress in Paris. SP14019 showed excellent safety and acceptability profile, clinically relevant and statistically significant efficacy with respect to placebo and very low systemic exposure to Cyclosporine A. - September 15, 2018 - Spherium Biomed

Experimentica Ltd. Presents at the ISER in Belfast, Northern Ireland - XXIII Biennial Meeting of the International Society for Eye Research September 9-13, 2018 | Belfast

The XXXIII Biennial Meeting of the International Society of Eye Research takes place this year from September 9-13th in Belfast, Northern Ireland, UK. Dr Jenni J. Hakkarainen – Acting COO of Experimentica Ltd. will present an oral presentation on a metalloporphyrin superoxide dismutase mimetic and the dry-eye disease. Dr Simon Kaja – CSO of Experimentica Ltd. will chair a session and present on cellular mechanisms of reactive astrocytosis and opportunities for glioprotection. - September 08, 2018 - Experimentica Ltd

Press Releases 201 - 250 of 2,966